ABS Direct Equity Fund LLC Purchases New Shares in Sotera Health Company $SHC

ABS Direct Equity Fund LLC purchased a new position in shares of Sotera Health Company (NASDAQ:SHC) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 50,000 shares of the company’s stock, valued at approximately $717,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. IFP Advisors Inc lifted its stake in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares in the last quarter. Rothschild Investment LLC acquired a new position in shares of Sotera Health in the 4th quarter valued at approximately $27,000. Root Financial Partners LLC boosted its stake in shares of Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after buying an additional 1,455 shares during the last quarter. Eurizon Capital SGR S.p.A. purchased a new position in shares of Sotera Health during the 4th quarter valued at approximately $40,000. Finally, Allworth Financial LP grew its position in shares of Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock worth $53,000 after buying an additional 2,729 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on SHC shares. UBS Group set a $19.00 price objective on shares of Sotera Health in a research note on Wednesday, June 24th. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Piper Sandler reissued an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Finally, Barclays increased their target price on Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Stock Performance

Shares of NASDAQ SHC opened at $17.35 on Monday. The stock has a market capitalization of $4.95 billion, a P/E ratio of 42.32 and a beta of 1.76. The firm’s 50-day moving average price is $16.65 and its two-hundred day moving average price is $16.38. Sotera Health Company has a 52-week low of $11.00 and a 52-week high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, sell-side analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current year.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 15.36% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.